IOVANCE BIOTHERAPEUTICS, INC. Origination of Notes Receivable from Related Parties
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Origination of Notes Receivable from Related Parties of $0 for the 60-month period ending 2012-09-30, per its 10-Q filed 2013-01-25.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OriginationOfNotesReceivableFromRelatedParties · last filed 2013-01-25
- 2012-09-30: Origination of Notes Receivable from Related Parties 9 month $0.00; Origination of Notes Receivable from Related Parties 60 month $0.00.
- 2011-09-30: Origination of Notes Receivable from Related Parties 9 month $50.00K.
| Period end | Origination of Notes Receivable from Related Parties 9 month | Origination of Notes Receivable from Related Parties 60 month |
|---|---|---|
| 2012-09-30 | $0.00 10-Q · filed 2013-01-25 | $0.00 10-Q · filed 2013-01-25 |
| 2011-09-30 | $50.00K 10-Q · filed 2013-01-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |